Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
TEVA PHARMA
Dec-13
SUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0723,479-   
Low Rs7903,022-   
Sales per share (Unadj.) Rs182.91,996.4-  
Earnings per share (Unadj.) Rs35.7124.7-  
Cash flow per share (Unadj.) Rs46.2286.1-  
Dividends per share (Unadj.) Rs11.50109.18-  
Avg Dividend yield %1.23.4 36.8%  
Book value per share (Unadj.) Rs233.42,217.6-  
Shares outstanding (eoy) m2,399.34848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.11.6 312.6%   
Avg P/E ratio x26.126.1 100.1%  
P/CF ratio (eoy) x20.111.4 177.3%  
Price / Book Value ratio x4.01.5 272.1%  
Dividend payout %32.287.5 36.8%   
Avg Mkt Cap Rs m2,233,3612,756,220 81.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m82,9600-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m438,8571,692,969 25.9%  
Other income Rs m8,1990-   
Total revenues Rs m447,0551,692,969 26.4%   
Gross profit Rs m112,900463,620 24.4%  
Depreciation Rs m25,294136,844 18.5%   
Interest Rs m1,72033,253 5.2%   
Profit before tax Rs m94,084293,523 32.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m8,476-3,584 -236.5%   
Profit after tax Rs m85,608105,758 80.9%  
Gross profit margin %25.727.4 93.9%  
Effective tax rate %9.0-1.2 -737.9%   
Net profit margin %19.56.2 312.3%  
BALANCE SHEET DATA
Current assets Rs m398,6191,143,425 34.9%   
Current liabilities Rs m199,064997,163 20.0%   
Net working cap to sales %45.58.6 526.3%  
Current ratio x2.01.1 174.6%  
Inventory Days Days14791 161.9%  
Debtors Days Days9596 99.2%  
Net fixed assets Rs m376,960552,961 68.2%   
Share capital Rs m2,3994,167 57.6%   
"Free" reserves Rs m557,5550-   
Net worth Rs m559,9541,880,567 29.8%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m775,7943,868,976 20.1%  
Interest coverage x55.79.8 566.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 129.3%   
Return on assets %11.33.6 313.3%  
Return on equity %15.35.6 271.9%  
Return on capital %17.14.9 346.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m82,5410-   
CASH FLOW
From Operations Rs m49,593269,772 18.4%  
From Investments Rs m-79,437-95,591 83.1%  
From Financial Activity Rs m23,761-323,609 -7.3%  
Net Cashflow Rs m1,155-149,429 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SUN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SUN PHARMA With: STRIDES PHARMA SCIENCE  KOPRAN.  EVEREST ORGANICS  NATURAL CAPS  SMS PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.